AI Article Synopsis

  • The study examined the expression of L-type amino acid transporter 1 (LAT1) and its subunit 4F2 heavy chain (4F2hc) in bone healing after a specific tooth ash and plaster implant in rats.
  • The rats were divided into a control group with only a soft tissue flap and an experimental group where the defect was filled with a tooth ash-plaster mixture, with analyses performed at 1, 2, 4, and 8 weeks post-operation.
  • Results indicated that LAT1 and 4F2hc were more actively expressed in the mixture group during the early stages of bone formation, suggesting these proteins may play a significant role in supplying necessary amino acids to support new bone development.

Article Abstract

Background: In order to elucidate the expression pattern of L-type amino acid transporter 1 (LAT1) in the bone formation process, the expressions of LAT1 and its subunit 4F2 heavy chain (4F2hc) were investigated in the healing process after the implantation of a tooth ash-plaster of Paris mixture in rats with calvarial osseous defect.

Materials And Methods: Circular calvarial defects (8 mm in diameter) were made midparietally. The rats were divided into 2 groups, 1 control group and 1 experimental group. In the control group, the defect was only covered with a soft tissue flap (control group); in the experimental group, it was filled with a mixture of tooth ash and plaster of Paris (2:1 by weight; mixture group). The rats were sacrificed at 1, 2, 4 and 8 weeks after operation and RT-PCR and immunohistochemical analyses were performed.

Results: In the RT-PCR analysis, the expressions of the LAT1 and 4F2hc mRNAs were slightly stronger in the experimental group than in the control group. In the immunohistochemical analysis, at 1 week after operation, the LAT1 protein and its subunit 4F2hc protein were mainly expressed in the osteoblasts, osteocytes and interstitial tissues of the area around the defect and the inner part of newly forming bone in both groups. The expressions of LAT1 and 4F2hc proteins were decreased at 2 and 4 weeks after operation. The LAT1 and 4F2hc proteins were scarcely expressed at 8 weeks after operation in both groups. The expressions of LAT1 and 4F2hc proteins were slightly stronger in the mixture group than in the control group.

Conclusion: These results suggest that the LAT1 and its subunit 4F2hc are highly expressed in the early stage of new bone formation and may have an important role in providing cells with neutral amino acids, including several essential amino acids, at that stage.

Download full-text PDF

Source

Publication Analysis

Top Keywords

lat1 4f2hc
20
expressions lat1
16
control group
16
experimental group
12
group control
12
weeks operation
12
4f2hc proteins
12
lat1
9
group
9
amino acid
8

Similar Publications

Article Synopsis
  • LAT1 is essential for transporting large neutral amino acids across the blood-brain barrier (BBB), influencing brain health and the delivery of drugs for neurological disorders.
  • Research has shown its significant role in improving drug efficacy in conditions like Alzheimer's, Parkinson's, and phenylketonuria, while also affecting treatment responses in neurodevelopment and neuropsychiatric disorders.
  • Innovative approaches like using prodrugs and functionalized nanoparticles are being explored to enhance drug delivery to the brain and overcome challenges like chemoresistance.
View Article and Find Full Text PDF

Structural basis for the inhibition mechanism of LAT1-4F2hc complex by JPH203.

Cell Discov

July 2024

Department of Biochemistry, School of Medicine, Key University Laboratory of Metabolism and Health of Guangdong, Institute for Biological Electron Microscopy, Southern University of Science and Technology, Shenzhen, Guangdong, China.

View Article and Find Full Text PDF

The transcorneal route is the main entry route for drugs to the intraocular parts, after topical administration. The outer surface, the corneal epithelium (CE), forms the rate-limiting barrier for drug permeability. Information about the role and protein expression of drug and amino acid transporter proteins in the CE is sparse and lacking.

View Article and Find Full Text PDF

Fall-calving primiparous beef females [body weight (BW): 451 ± 28 (SD) kg; body condition score (BCS): 5.4 ± 0.7] were individually-fed either 100% (control; CON; n = 13) or 70% (nutrient restricted; NR; n = 13) of metabolizable energy and metabolizable protein requirements for maintenance, pregnancy, and growth from day 160 of gestation to parturition.

View Article and Find Full Text PDF

FOXC1 regulates endothelial CD98 (LAT1/4F2hc) expression in retinal angiogenesis and blood-retina barrier formation.

Nat Commun

May 2024

Department of Medicine, Feinberg Cardiovascular and Renal Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Article Synopsis
  • - Angiogenesis is the process of forming new blood vessels, which is vital for organ development, but how it's controlled at the genetic level is not fully understood.
  • - Research shows that the gene FOXC1 is crucial for the growth of blood vessels in the retina; its loss affects certain amino acid transporters and reduces activity of the mTOR pathway, which is important for cell growth.
  • - FOXC1 is necessary not only for retinal blood vessel formation but also for the function of pericytes, essential for the blood-retina barrier, highlighting its potential as a target for therapies aimed at retinal vascular diseases.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!